SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

6MD (6MD) News

Follow 6MD (6MD) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol 6MD Asset market Sector Markets 90 days 7 Updated Sep 15, 2026, 07:31 AM UTC Open live news feed
L Medacta to Keep Growing But Faces Normalization — Market Talk Medacta should continue to book above-market growth rates but market expectations currently underestimate growth normalization and the investment required to sustain expansion, Deutsche Bank says in a research note. "Whi NEWS | Sep 15, 2026, 07:31 AM UTC L Medacta Target Started at CHF121 by Deutsche Bank Medacta Target Started at CHF121 by Deutsche Bank NEWS | Sep 15, 2026, 06:28 AM UTC L Medacta Started at Hold by Deutsche Bank Medacta Started at Hold by Deutsche Bank NEWS | Sep 15, 2026, 06:28 AM UTC L Medacta Group H1 2026 revenue up nearly 10% to EUR 368 million Medacta Group said H1 2026 revenue rose nearly 10% to EUR 368 million. Growth was strong across most regions and segments, but gross margin fell due to FX and mix effects. EARNINGS | Sep 09, 2026, 03:06 PM UTC L Medacta H1 2026 revenue up; EBITDA margin 27.8% constant-currency Medacta Group says H1 2026 revenue rose nearly 10% to EUR 368 million. Adjusted EBITDA margin was 27.8% at constant currency. Guidance for 10%-14% revenue growth and margin expansion is confirmed. EARNINGS | Sep 09, 2026, 02:18 PM UTC L Swiss medical device maker Medacta H1 revenue rises on Asia Pacific, EMEA strength OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed EQUITY | Sep 09, 2026, 05:10 AM UTC L Medacta Group H1 2026 revenue and margin growth; guidance confirmed H1 2026 revenue rose 9.7% in constant currency; adjusted EBITDA margin was 27.8%. Net profit was EUR 41.9m, impacted by last year’s one-off gain. Guidance for double-digit growth and margin expansion is confirmed. EARNINGS | Sep 09, 2026, 05:03 AM UTC